• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • New cancer drug could give hope to non-responsive patients pharmafile
    February 16, 2017
    A new dual action drug developed as part of a collaboration between biopharmaceutical oncology firm Almac Discovery and The Royal College of Surgeons in Ireland (RCSI) could be used to treat cancer patients in whom all other treatment avenues have failed.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service